Femasys (FEMY) Revenue (2020 - 2026)
Femasys' (FEMY) quarterly Revenue came in at $331827.0 in Q2 2026, down 18.92% on a YoY basis from $409268.0 in Q2 2025, and down 18.92% quarter-over-quarter from $409268.0 in Q2 2025.
Powered by 
Analysis
Femasys (FEMY) Revenue (2020 - 2026) Analysis & Trends
Femasys (FEMY) has reported Revenue for 7 consecutive years, with $331827.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Revenue fell 18.92% year-over-year to $331827.0; the trailing twelve-month figure through Jun 2026 stood at $1.7 million (down 11.82% YoY), and the FY2025 full-year result was $2.3 million, up 40.77% from the prior year.
- Revenue declined to $331827.0 in Q2 2026 per FEMY's latest filing, from $409268.0 in the prior quarter.
- Across five years, Revenue topped out at $581576.0 in Q4 2024 and bottomed at $213111.0 in Q4 2023.
- Historically, Revenue has averaged $332643.7 across 5 years, with a median of $320514.0 in 2023.
- The widest YoY moves for Revenue: up 172.9% in 2024, down 30.9% in 2024.
- Over 5 years, Revenue stood at $234244.0 in 2022, then declined by 9.02% to $213111.0 in 2023, then surged by 172.9% to $581576.0 in 2024, then slipped by 29.63% to $409268.0 in 2025, then slipped by 18.92% to $331827.0 in 2026.
- According to Business Quant data, Revenue over the past three periods registered $331827.0, $409268.0, and $341264.0 for Q2 2026, Q2 2025, and Q1 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 12.59 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 2.89 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 9.76 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 6.59 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 5.44 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 1.74 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 2.78 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 1.31 Bn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 1.49 Bn |
| 10 | Femasys | 9.37 Mn | 7.92 Mn | 189,391.00 | 331,827.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 331,827.00 |
| Jun 30, 2025 | 409,268.00 |
| Mar 31, 2025 | 341,264.00 |
| Dec 31, 2024 | 581,576.00 |
| Sep 30, 2024 | 554,908.00 |
| Jun 30, 2024 | 221,484.00 |
| Mar 31, 2024 | 271,140.00 |
| Dec 31, 2023 | 213,111.00 |
| Sep 30, 2023 | 244,361.00 |
| Jun 30, 2023 | 320,514.00 |
| Mar 31, 2023 | 293,984.00 |
| Dec 31, 2022 | 234,244.00 |
| Sep 30, 2022 | 347,456.00 |
| Jun 30, 2022 | 303,113.00 |
| Mar 31, 2022 | 321,405.00 |
| Dec 31, 2021 | 254,327.00 |
| Sep 30, 2021 | 269,581.00 |
| Jun 30, 2021 | 326,006.00 |
| Mar 31, 2021 | 329,775.00 |
| Dec 31, 2020 | 280,964.00 |